Turmeric Acquisition Corp. is a special purpose acquisition company (SPAC) that raised $85M in its initial public offering in October 2020. The company is listed on the Nasdaq with the common shares trading under the symbol “TMPM” and is targeting a merger with a biopharmaceutical company developing novel therapies for its initial business combination.

 

For more information, please contact us or view our latest public filings.

 

Download documents:

• Compensation Committee Charter
• Audit Committee Charter
• Code of Conducts and Ethics
• Nominating and Corporate Governance Committee Charter
• TAC Class A – PFIC Annual Information Statement